Vident Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,469
| Closed | -$1.81M | – | 960 |
|
|
2023
Q2 | $1.81M | Sell |
3,469
-1,768
| -34% | -$923K | 0.06% | 333 |
|
|
2023
Q1 | $3.02M | Sell |
5,237
-9,687
| -65% | -$5.58M | 0.1% | 226 |
|
|
2022
Q4 | $8.22M | Buy |
14,924
+9,194
| +160% | +$5.06M | 0.31% | 73 |
|
|
2022
Q3 | $2.57M | Buy |
5,730
+359
| +7% | +$161K | 0.08% | 268 |
|
|
2022
Q2 | $2.92M | Buy |
5,371
+2,153
| +67% | +$1.17M | 0.09% | 267 |
|
|
2022
Q1 | $1.9M | Sell |
3,218
-1,500
| -32% | -$887K | 0.05% | 477 |
|
|
2021
Q4 | $3.15M | Sell |
4,718
-69
| -1% | -$46K | 0.08% | 280 |
|
|
2021
Q3 | $2.74M | Sell |
4,787
-8,040
| -63% | -$4.59M | 0.08% | 266 |
|
|
2021
Q2 | $6.47M | Buy |
12,827
+1,400
| +12% | +$706K | 0.2% | 90 |
|
|
2021
Q1 | $5.22M | Buy |
11,427
+7,974
| +231% | +$3.64M | 0.18% | 101 |
|
|
2020
Q4 | $1.61M | Sell |
3,453
-21
| -0.6% | -$9.79K | 0.07% | 372 |
|
|
2020
Q3 | $1.53M | Buy |
3,474
+307
| +10% | +$136K | 0.08% | 350 |
|
|
2020
Q2 | $1.15M | Buy |
3,167
+2,221
| +235% | +$805K | 0.06% | 433 |
|
|
2020
Q1 | $268K | Buy |
+946
| New | +$268K | 0.02% | 704 |
|
|
2018
Q2 | – | Sell |
-1,916
| Closed | -$415K | – | 970 |
|
|
2018
Q1 | $415K | Sell |
1,916
-469
| -20% | -$102K | 0.02% | 691 |
|
|
2017
Q4 | $452K | Buy |
+2,385
| New | +$452K | 0.02% | 603 |
|
|
2015
Q4 | – | Sell |
-30
| Closed | -$4K | – | 802 |
|
|
2015
Q3 | $4K | Buy |
30
+5
| +20% | +$667 | ﹤0.01% | 922 |
|
|
2015
Q2 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 1047 |
|